Quantifying the feasibility of shortening clinical trial duration using surrogate markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantifying the feasibility of shortening clinical trial duration using surrogate markers

Published:2021-09-02 Issue:28 Volume:40 Page:6321-6343
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Wang Xuan¹^ORCID,Cai Tianxi¹²,Tian Lu³^ORCID,Bourgeois Florence⁴,Parast Layla⁵^ORCID

Affiliation:

1. Department of Biostatistics Harvard University Boston Massachusetts USA

2. Department of Biomedical Informatics Harvard University Boston Massachusetts USA

3. Department of Biomedical Data Science Stanford University Stanford California USA

4. Harvard‐MIT Center for Regulatory Science Boston Massachusetts USA

5. Statistics Group RAND Corporation Santa Monica California USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Natural Science Foundation of China

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9185

Reference30 articles.

1. Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials

2. Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

3. FDATable of surrogate endpoints that were the basis of drug approval or licensure; 2020.https://www.fda.gov/drugs/development‐resources/table‐surrogate‐endpoints‐we%re‐basis‐drug‐approval‐or‐licensure.

4. Surrogate endpoints in clinical trials: Definition and operational criteria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP